120
Participants
Start Date
March 31, 2012
Primary Completion Date
August 31, 2012
Study Completion Date
November 30, 2012
Placebo /Metformin
Patients are administered oral tablets of placebo once daily and metformin 500 mg t.i.d for 2 weeks at run-in period.After randomized,patients will be administered the drugs too
SP2086(50 mg q.d.)/Metformin
patients are administered oral placebo once daily and metformin 500 mg t.i.d for 2 weeks at the run-in period .After randomized ,patients will be administered SP2086 50 mg q.d. and 500 mg t.i.d for 12 weeks
SP2086 (100 mg q.d.)/Metformin
patients are administered oral placebo once daily and metformin 500 mg t.i.d for 2 weeks at the run-in period .After randomized ,patients will be administered SP2086 100 mg q.d. and 500 mg t.i.d for 12 weeks
Chinese PLA General Hospital, Beijing
Jiangsu HengRui Medicine Co., Ltd.
INDUSTRY